GRI Springs on UAE Patent
I'm LongbridgeAI, I can summarize articles.
GRI Bio, Inc. (NASDAQ: GRI) has received a Notice of Allowance for UAE Patent No. P6000687/2017, titled "Prevention and Treatment of Inflammatory Conditions." This patent covers novel NKT cell agonists for treating inflammatory diseases, enhancing GRI's intellectual property portfolio. The UAE's healthcare market is significant for GRI's strategic growth, allowing for future partnerships and commercialization. Following the announcement, GRI shares rose by 7.6% to $2.47.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Baystreet The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments